Fedorinov, D.; Lyadov, V.; Lyadova, M.; Abdullaev, S.; Kachanova, A.; Filatova, A.; Ivashchenko, D.; Sychev, D.
Impact of Pharmacogenetic Markers on the Efficacy of Neoadjuvant FLOT Chemotherapy in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma. Int. J. Mol. Sci. 2026, 27, 4114.
https://doi.org/10.3390/ijms27094114
AMA Style
Fedorinov D, Lyadov V, Lyadova M, Abdullaev S, Kachanova A, Filatova A, Ivashchenko D, Sychev D.
Impact of Pharmacogenetic Markers on the Efficacy of Neoadjuvant FLOT Chemotherapy in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma. International Journal of Molecular Sciences. 2026; 27(9):4114.
https://doi.org/10.3390/ijms27094114
Chicago/Turabian Style
Fedorinov, Denis, Vladimir Lyadov, Marina Lyadova, Sherzod Abdullaev, Anastasia Kachanova, Anna Filatova, Dmitriy Ivashchenko, and Dmitry Sychev.
2026. "Impact of Pharmacogenetic Markers on the Efficacy of Neoadjuvant FLOT Chemotherapy in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma" International Journal of Molecular Sciences 27, no. 9: 4114.
https://doi.org/10.3390/ijms27094114
APA Style
Fedorinov, D., Lyadov, V., Lyadova, M., Abdullaev, S., Kachanova, A., Filatova, A., Ivashchenko, D., & Sychev, D.
(2026). Impact of Pharmacogenetic Markers on the Efficacy of Neoadjuvant FLOT Chemotherapy in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma. International Journal of Molecular Sciences, 27(9), 4114.
https://doi.org/10.3390/ijms27094114